Ratings by Ladenburg Thalmann (Michael Higgins)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2024 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Zynerba Pharmaceuticals | ZYNE | Downgrade | Neutral (Buy) |
0.34 (1.30) |
282.35% | Details | |
| 12/22/2022 | Zynerba Pharmaceuticals | ZYNE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2022 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | Rhythm Pharmaceuticals | RYTM | Upgrade | Buy (Neutral) |
6.63 (39.71) |
498.94% | Details | |
| 11/12/2021 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2021 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2021 | Tryp Therapeutics | TRYPF | New Coverage | Buy (N/A) |
0.37 (0.04) |
-89.19% | Details | |
| 8/16/2021 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | Rhythm Pharmaceuticals | RYTM | Downgrade | Neutral (Buy) |
16.63 (39.71) |
138.79% | Details | |
| 5/13/2021 | 4D Pharma PLC | LBPS | New Coverage | Buy (N/A) |
10.55 (1.65) |
-84.36% | Details | |
| 5/12/2021 | Catabasis | CATB | New Coverage | Buy (N/A) |
1.78 (8.54) |
379.78% | Details | |
| 3/30/2021 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2021 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2021 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
21.78 (13.03) |
-40.17% | Details | |
| 12/16/2020 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2020 | Intec Pharma Ltd. | NTEC | Upgrade | Buy (Neutral) |
3.46 (9.63) |
178.32% | Details | |
| 8/5/2020 | Novavax | NVAX | Downgrade | Sell (Neutral) |
157.17 (4.15) |
-97.36% | Details | |
| 7/8/2020 | Novavax | NVAX | Downgrade | Neutral (Buy) |
104.56 (4.15) |
-96.03% | Details | |
| 6/2/2020 | Novus Therapeutics, Inc | NVUS | Downgrade | Neutral (Buy) |
0.62 (14.60) |
2254.84% | Details | |
| 5/14/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2020 | Savara | SVRA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2020 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2020 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/12/2020 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | Zogenix, Inc. | ZGNX | Downgrade | Neutral (Buy) |
52.62 (26.68) |
-49.3% | Details | |
| 1/27/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2019 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
60.18 (14.00) |
-76.74% | Details | |
| 6/19/2019 | Armata Pharmaceuticals | ARMP | New Coverage | Buy (N/A) |
2.80 (2.50) |
-10.71% | Details | |
| 6/13/2019 | Savara | SVRA | Downgrade | Neutral (Buy) |
10.57 (4.24) |
-59.89% | Details | |
| 6/11/2019 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2019 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | Rhythm Pharmaceuticals | RYTM | New Coverage | Buy (N/A) |
29.17 (39.71) |
36.13% | Details | |
| 3/6/2019 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2019 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2018 | Cerecor | CERC | New Coverage | Buy (N/A) |
3.27 (2.93) |
-10.4% | Details | |
| 12/18/2018 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
6.01 (2.23) |
-62.9% | Details | |
| 12/18/2018 | Melinta Therapeutics Inc. | MLNT | New Coverage | Buy (N/A) |
1.18 (0.50) |
-57.63% | Details | |
| 12/11/2018 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2018 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2018 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2018 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2018 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2018 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2018 | Novus Therapeutics, Inc | NVUS | New Coverage | Buy (N/A) |
4.55 (14.60) |
220.88% | Details | |
| 8/23/2018 | Zogenix, Inc. | ZGNX | New Coverage | Buy (N/A) |
46.90 (52.62) |
12.2% | Details | |
| 8/20/2018 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
2.84 (4.54) |
59.86% | Details | |
| 8/16/2018 | AcelRx Pharmaceuticals | ACRX | New Coverage | Buy (N/A) |
3.05 (0.86) |
-71.8% | Details |
